2nd Circuit Says Marketing, Sales Claims In Rapid Release Tylenol Class Preempted
NEW YORK — A federal court properly found that the marketing and pricing claims alleging that Johnson & Johnson Consumer Inc. (JJCI) improperly advertised that its Tylenol Rapid Release Gelcaps worked...To view the full article, register now.
Already a subscriber? Click here to view full article